Information
-
Trademark
-
88760741
-
International Classifications
-
Filing Date
January 15, 2020
4 years ago
-
Transaction Date
February 12, 2024
8 months ago
-
Status Date
February 12, 2024
8 months ago
-
Location Date
February 12, 2024
8 months ago
-
Status Code
602
-
Current Location
TMO LAW OFFICE 118- EXAMINING ATTORNEY ASSIGNED
Employee Name
FARRELL, ANNE M
-
Attorney Docket Number
114384-0005
Attorney Name
Rachelle A. Dubow, Esq.
Law Office Assigned Location Code
M90
-
Owners
Mark Drawing Code
4000
Mark Identification
ORIONIS
Case File Statements
- GS0051: Pharmaceutical products, serums and preparations for the treatment of cancer, auto immune disorders, metabolic disorders, neurological disorders, neuromuscular disorder; cytokines, namely, reagents for scientific and research use; pharmaceutical preparations, namely, cytokine inhibitory drugs; Therapeutic pharmaceutical and diagnostic preparations, namely, antibodies, cytokines, antigens, enzymes, immunoconjugates for treatment of cancer, immunological conditions, metabolic disorders; Biochemical and small molecule preparations for medical purposes for use in the treatment of cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
- PM0001: ORION IS
- GS0011: Diagnostic, biological and chemical reagents for scientific and research use; pharmaceutical intermediates for use in the further manufacture of pharmaceuticals; Active chemical or biological ingredients for use in the manufacture of pharmaceuticals for treating cancer, auto immune diseases, metabolic diseases, neurological diseases, neuromuscular diseases
- GS0421: Development of new technology for others in the field of biotechnology; scientific research and laboratory research services in the medical, bacteriological and biotechnical fields; biotechnical research; technical consultation and research in the field of biotechnological research; Consulting services in the fields of biotechnology, pharmaceutical research and development, laboratory testing, diagnostics, and pharmacogenetics; research and development of pharmaceuticals for others; scientific and medical research in the fields of oncology, immunology and immune-oncology, inflammation, immune-mediated diseases, protein homeostasis, epigenetics and protein metabolism
Case File Event Statements
-
2/12/2024 - 8 months ago
22 - ABANDONMENT NOTICE E-MAILED - FAILURE TO RESPOND
Type: MAB2
-
2/12/2024 - 8 months ago
21 - ABANDONMENT - FAILURE TO RESPOND OR LATE RESPONSE
Type: ABN2
-
10/27/2023 - a year ago
20 - NOTIFICATION OF FINAL REFUSAL EMAILED
Type: GNFN
-
10/27/2023 - a year ago
19 - FINAL REFUSAL E-MAILED
Type: GNFR
-
10/27/2023 - a year ago
18 - FINAL REFUSAL WRITTEN
Type: CNFR
-
9/27/2023 - a year ago
17 - SUSPENSION CHECKED - TO ATTORNEY FOR ACTION
Type: RCCK
-
1/31/2023 - a year ago
16 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
6/1/2022 - 2 years ago
15 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
10/29/2021 - 3 years ago
14 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
4/23/2021 - 3 years ago
13 - REPORT COMPLETED SUSPENSION CHECK CASE STILL SUSPENDED
Type: RCSC
-
8/10/2020 - 4 years ago
12 - NOTIFICATION OF LETTER OF SUSPENSION E-MAILED
Type: GNS3
-
8/10/2020 - 4 years ago
11 - LETTER OF SUSPENSION E-MAILED
Type: GNSL
-
8/10/2020 - 4 years ago
10 - SUSPENSION LETTER WRITTEN
Type: CNSL
-
7/20/2020 - 4 years ago
9 - TEAS/EMAIL CORRESPONDENCE ENTERED
Type: TEME
-
7/20/2020 - 4 years ago
8 - CORRESPONDENCE RECEIVED IN LAW OFFICE
Type: CRFA
-
7/20/2020 - 4 years ago
7 - TEAS RESPONSE TO OFFICE ACTION RECEIVED
Type: TROA
-
3/25/2020 - 4 years ago
6 - NOTIFICATION OF NON-FINAL ACTION E-MAILED
Type: GNRN
-
3/25/2020 - 4 years ago
5 - NON-FINAL ACTION E-MAILED
Type: GNRT
-
3/25/2020 - 4 years ago
4 - NON-FINAL ACTION WRITTEN
Type: CNRT
-
3/24/2020 - 4 years ago
3 - ASSIGNED TO EXAMINER
Type: DOCK
-
1/22/2020 - 4 years ago
2 - NEW APPLICATION OFFICE SUPPLIED DATA ENTERED
Type: NWOS
-
1/18/2020 - 4 years ago
1 - NEW APPLICATION ENTERED
Type: NWAP